Science News -- ScienceDaily
• September 17, 2026 • By Briceka Curated
New mesothelioma drug turns cancer’s own defenses against it
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers.
Read the Full Article
Continue reading this story on the original source website.
About this Curated Preview
This article preview is part of the Science News -- ScienceDaily feed, carefully curated and indexed by Briceka to provide quick, accessible insights from trusted sources across the web.
Briceka is committed to organizing the world's information. By providing structured, fast-loading previews of external content, we help readers discover valuable information efficiently while supporting original creators. For the complete context, images, and interactive elements, please use the button above to visit the original publisher's website.